|
|
 |
|
Forest has partnered with other companies in drug development and marketing for more than 12 years. You can view highlights of our licensees and co-promotion agreements below.
Highlights of Licensees and Co-promotions (in order of most recent agreement)
| Product Brand/Generic |
Partner |
Therapeutic Area |
Stage When Licensed |
Launch Date |
Agreement Signed |
| Faropenem medoxomil |
Replidyne, Inc. |
Infectious Diseases |
NDA submission |
Pending approval of submission |
2006 |
| Nebivolol |
Mylan Laboratories |
Hypertension |
NDA approvable |
Pending submission of additional data |
2006 |
| Nebivolol |
Mylan Laboratories |
Congestive Heart Failure |
Phase III |
In development |
2006 |
| mGLUR1/5 Compounds |
Gedeon Richter |
Anxiety, Depression and Various CNS Conditions |
Pre-clinical |
In development |
2005 |
| RGH-896 |
Gedeon Richter |
Chronic Pain and Various CNS Conditions |
Phase I |
In development |
2005 |
| GRC 3886 |
Glenmark Pharmaceuticals |
Chronic Obstructive Pulmonary Disorder (COPD) and Asthma |
Phase I |
In development |
2004 |
| Desmoteplase |
Paion AG |
Acute Ischemic Stroke |
Phase IIb/III |
In development |
2004 |
| Milnacipran |
Cypress
Bioscience/Pierre
Fabre
| Fibromyalgia |
Phase III |
In development |
2004 |
Benicar®/olmesartan
medoxomil,
Benicar HCT® /olmesartan
medoxomil -
hydrochlorothiazide |
Daiichi Sankyo Pharma
(co-promotion) |
Cardiovascular/ Hypertension |
NDA submission |
2002 |
2001 |
| Campral®/acamprosate calcium |
Merck Santé |
Alcohol Dependence |
Phase III |
2005 |
2001 |
| Lercanidipine |
Recordati |
Cardiovascular/ hypertension |
Phase III |
In development |
2000 |
| Namenda®/memantine |
Merz |
Alzheimer’s Disease |
Phase III |
2004 |
2000 |
Lexapro®/escitalopram
oxalate |
Lundbeck |
Major Depressive Disorder,
Generalized Anxiety Disorder in Adults |
Preclinical |
2002, 2003 |
1998 |
| Celexa®/citalopram |
Lundbeck |
Depression |
Phase III |
1998 |
1996 |
Combunox®/oxycodone
HCl and ibuprofen |
BTG |
Pain |
Phase II |
2005 |
1996 |
| Climara® |
Schering AG
(copromotion) |
Estrogen Replacement |
Launched |
1995 |
1995 |
| Tiazac® |
Biovail |
Cardiovascular/ hypertension |
NDA Filed |
1996 |
1995 |
| Cervidil® |
PharmaSciences |
Cervical Ripening |
NDA Filed |
1993 |
1995 |
|
|